A sensitive “Switch-on” phosphorescent probe for ferrous iron quantification in drug and In vitro imaging of living cells

Sili Yi,Ziwen Qiao,Zhen Lu,Yandai Lin,Jun Wang,Jin Zhang,Linxi Hou
DOI: https://doi.org/10.1016/j.talanta.2020.121097
IF: 6.1
2020-09-01
Talanta
Abstract:<p>Iron plays an important role in various physiological processes. However, the detailed biological functions of iron have not been sufficiently explored because of a lack of effective methods to monitoring iron, especially the labile ferrous ion (Fe<sup>2+</sup>). In the current study, a novel turn-on phosphorescent probe for Fe<sup>2+</sup> quantification and visualization has been proposed based on the hybrid nanocomposite of manganese dioxide and gemini iridium complex (MnO<sub>2</sub>-GM-Ir). The surfactant-like GM-Ir with positive charges was beneficial to combine with the negatively charged manganese dioxide (MnO<sub>2</sub>) nanosheets, and thus endowing the MnO<sub>2</sub>-GM-Ir nanocomposite excellent dispersion ability in the water as well as efficiently avoiding the interference to the detection caused by the agglomeration of nanocomposite. Phosphorescence of GM-Ir was effectively quenched by MnO<sub>2</sub> nanosheets through fluorescence resonance energy transfer (FRET) and the inner filter effect (IFE), while the phosphorescence could be significantly recovered in the presence of Fe<sup>2+</sup> <em>via</em> a selective Fe<sup>2+</sup>-mediated reduction of MnO<sub>2</sub> nanosheets, indicating a highly-specific selectivity towards Fe<sup>2+</sup> with a low detection limit (80 nM). The drug test assay and <em>in vitro</em> imaging studies further proved that the MnO<sub>2</sub>-GM-Ir nanocomposite could be employed as a promising probe for the quantitative detection of exogenous Fe<sup>2+</sup> in drug and <em>in vitro</em> imaging of living cells.</p>
chemistry, analytical
What problem does this paper attempt to address?